These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Molecular mechanisms of fluconazole resistance in clinical isolates of Candida glabrata]. Shen YZ; Lu HZ; Zhang YX Zhonghua Nei Ke Za Zhi; 2010 Mar; 49(3):245-9. PubMed ID: 20450660 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance. Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750 [TBL] [Abstract][Full Text] [Related]
6. Contribution of CgPDR1-regulated genes in enhanced virulence of azole-resistant Candida glabrata. Ferrari S; Sanguinetti M; Torelli R; Posteraro B; Sanglard D PLoS One; 2011 Mar; 6(3):e17589. PubMed ID: 21408004 [TBL] [Abstract][Full Text] [Related]
7. Resistance reversal induced by a combination of fluconazole and tacrolimus (FK506) in Candida glabrata. Li H; Chen Z; Zhang C; Gao Y; Zhang X; Sun S J Med Microbiol; 2015 Jan; 64(Pt 1):44-52. PubMed ID: 25355935 [TBL] [Abstract][Full Text] [Related]
8. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms. Sanglard D; Coste AT Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310 [TBL] [Abstract][Full Text] [Related]
9. Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole. Borst A; Raimer MT; Warnock DW; Morrison CJ; Arthington-Skaggs BA Antimicrob Agents Chemother; 2005 Feb; 49(2):783-7. PubMed ID: 15673768 [TBL] [Abstract][Full Text] [Related]
10. Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor. Vermitsky JP; Edlind TD Antimicrob Agents Chemother; 2004 Oct; 48(10):3773-81. PubMed ID: 15388433 [TBL] [Abstract][Full Text] [Related]
12. Construction and Use of a Recyclable Marker To Examine the Role of Major Facilitator Superfamily Protein Members in Vu BG; Moye-Rowley WS mSphere; 2018; 3(2):. PubMed ID: 29600281 [No Abstract] [Full Text] [Related]
13. Clonal Spread of Candida glabrata Bloodstream Isolates and Fluconazole Resistance Affected by Prolonged Exposure: a 12-Year Single-Center Study in Belgium. Goemaere B; Lagrou K; Spriet I; Hendrickx M; Becker P Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29784839 [No Abstract] [Full Text] [Related]
14. Expression of ERG11 and efflux pump genes CDR1, CDR2 and SNQ2 in voriconazole susceptible and resistant Candida glabrata strains. Navarro-Rodríguez P; Martin-Vicente A; López-Fernández L; Guarro J; Capilla J Med Mycol; 2020 Jan; 58(1):30-38. PubMed ID: 30843047 [TBL] [Abstract][Full Text] [Related]
15. Transcriptome Analysis Unveils Gln3 Role in Amino Acids Assimilation and Fluconazole Resistance in Pérez-de Los Santos FJ; García-Ortega LF; Robledo-Márquez K; Guzmán-Moreno J; Riego-Ruiz L J Microbiol Biotechnol; 2021 May; 31(5):659-666. PubMed ID: 33879640 [TBL] [Abstract][Full Text] [Related]
16. Microarray and molecular analyses of the azole resistance mechanism in Candida glabrata oropharyngeal isolates. Tsai HF; Sammons LR; Zhang X; Suffis SD; Su Q; Myers TG; Marr KA; Bennett JE Antimicrob Agents Chemother; 2010 Aug; 54(8):3308-17. PubMed ID: 20547810 [TBL] [Abstract][Full Text] [Related]
17. A Transcriptomics Approach To Unveiling the Mechanisms of Cavalheiro M; Costa C; Silva-Dias A; Miranda IM; Wang C; Pais P; Pinto SN; Mil-Homens D; Sato-Okamoto M; Takahashi-Nakaguchi A; Silva RM; Mira NP; Fialho AM; Chibana H; Rodrigues AG; Butler G; Teixeira MC Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30348666 [No Abstract] [Full Text] [Related]
18. Drug susceptibility profile of Candida glabrata clinical isolates from Iran and genetic resistant mechanisms to caspofungin. Amanloo S; Shams-Ghahfarokhi M; Ghahri M; Razzaghi-Abyaneh M Rev Iberoam Micol; 2018; 35(2):88-91. PubMed ID: 29685375 [TBL] [Abstract][Full Text] [Related]